These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 10200532

  • 1. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L.
    Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
    [Abstract] [Full Text] [Related]

  • 2. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC, López-Rivas A.
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [Abstract] [Full Text] [Related]

  • 3. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
    Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY.
    Biochem Pharmacol; 2004 Jul 15; 68(2):293-303. PubMed ID: 15194001
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
    Winter S, Weller M.
    J Pharmacol Exp Ther; 1998 Sep 15; 286(3):1374-82. PubMed ID: 9732400
    [Abstract] [Full Text] [Related]

  • 5. The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis.
    Müller M, Scaffidi CA, Galle PR, Stremmel W, Krammer PH.
    Eur Cytokine Netw; 1998 Dec 15; 9(4):685-6. PubMed ID: 9889415
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
    Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM.
    Cancer Res; 1997 Sep 01; 57(17):3823-9. PubMed ID: 9288794
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O.
    Cancer Res; 2000 Jun 01; 60(11):2912-8. PubMed ID: 10850437
    [Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, Pantazis P.
    Cancer Res; 2001 Oct 01; 61(19):7148-54. PubMed ID: 11585748
    [Abstract] [Full Text] [Related]

  • 10. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC, de Vries EG, Vellenga E, de Jong S.
    Cell Death Differ; 2003 Jul 01; 10(7):808-22. PubMed ID: 12815464
    [Abstract] [Full Text] [Related]

  • 11. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
    Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC.
    Cancer Res; 1998 Dec 01; 58(23):5315-20. PubMed ID: 9850056
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
    Zhu J, Okumura H, Ohtake S, Nakamura S, Nakao S.
    Oncol Rep; 2003 Dec 01; 10(3):705-9. PubMed ID: 12684647
    [Abstract] [Full Text] [Related]

  • 16. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA, Tanaka N.
    Oncogene; 1999 Apr 01; 18(13):2189-99. PubMed ID: 10327065
    [Abstract] [Full Text] [Related]

  • 17. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM.
    Oncogene; 2001 Mar 01; 20(9):1063-75. PubMed ID: 11314043
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel induces apoptosis in Saos-2 cells with CD95L upregulation and Bcl-2 phosphorylation.
    Pucci B, Bellincampi L, Tafani M, Masciullo V, Melino G, Giordano A.
    Exp Cell Res; 1999 Oct 10; 252(1):134-43. PubMed ID: 10502406
    [Abstract] [Full Text] [Related]

  • 19. Drug-induced apoptosis in osteosarcoma cell lines is mediated by caspase activation independent of CD95-receptor/ligand interaction.
    Fellenberg J, Mau H, Nedel S, Ewerbeck V, Debatin KM.
    J Orthop Res; 2000 Jan 10; 18(1):10-7. PubMed ID: 10716273
    [Abstract] [Full Text] [Related]

  • 20. Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells.
    Petak I, Tillman DM, Harwood FG, Mihalik R, Houghton JA.
    Cancer Res; 2000 May 15; 60(10):2643-50. PubMed ID: 10825136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.